Exosomal microRNAs as tumor markers in epithelial ovarian cancer. 2018

Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany.

Specific microRNAs (miRNAs) are packaged in exosomes that regulate processes in tumor development and progression. The current study focuses on the influence of exosomal miRNAs in the pathogenesis of epithelial ovarian cancer (EOC). MiRNA profiles were determined in exosomes from plasma of 106 EOC patients, eight ovarian cystadenoma patients, and 29 healthy women by TaqMan real-time PCR-based miRNA array cards containing 48 different miRNAs. In cell culture experiments, the impact of miR-200b and miR-320 was determined on proliferation and apoptosis of ovarian cancer cell lines. We report that miR-21 (P = 0.0001), miR-100 (P = 0.034), miR-200b (P = 0.008), and miR-320 (P = 0.034) are significantly enriched, whereas miR-16 (P = 0.009), miR-93 (P = 0.014), miR-126 (P = 0.012), and miR-223 (P = 0.029) are underrepresented in exosomes from plasma of EOC patients as compared to those of healthy women. The levels of exosomal miR-23a (P = 0.009, 0.008) and miR-92a (P = 009, 0.034) were lower in ovarian cystadenoma patients than in EOC patients and healthy women, respectively. The exosomal levels of miR-200b correlated with the tumor marker CA125 (P = 0.002) and patient overall survival (P = 0.019). MiR-200b influenced cell proliferation (P = 0.0001) and apoptosis (P < 0.008). Our findings reveal specific exosomal miRNA patterns in EOC and ovarian cystadenoma patients, which are indicative of a role of these miRNAs in the pathogenesis of EOC.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D003537 Cystadenoma A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed) Cystadenomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074166 Circulating MicroRNA MicroRNAs found in cell-free BODY FLUIDS such as SERUM; PLASMA; SALIVA; OR URINE. Cell-Free MicroRNA,Cell Free MicroRNA,MicroRNA, Cell-Free,MicroRNA, Circulating
D000077216 Carcinoma, Ovarian Epithelial A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer. Epithelial Ovarian Cancer,Epithelial Ovarian Carcinoma,Ovarian Cancer, Epithelial,Ovarian Epithelial Cancer,Ovarian Epithelial Carcinoma,Cancer, Epithelial Ovarian,Cancer, Ovarian Epithelial,Carcinoma, Epithelial Ovarian,Epithelial Cancer, Ovarian,Epithelial Carcinoma, Ovarian,Epithelial Ovarian Cancers,Epithelial Ovarian Carcinomas,Ovarian Carcinoma, Epithelial,Ovarian Epithelial Cancers,Ovarian Epithelial Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
August 2003, Minerva ginecologica,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
June 2014, Molecular and cellular endocrinology,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
October 2021, Biomedicines,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
May 2021, Experimental biology and medicine (Maywood, N.J.),
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
March 1994, Obstetrics and gynecology clinics of North America,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
May 1984, American journal of obstetrics and gynecology,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
May 2004, Ceska gynekologie,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
January 2021, American journal of translational research,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
April 2020, Journal of ovarian research,
Chi Pan, and Ines Stevic, and Volkmar Müller, and Qingtao Ni, and Leticia Oliveira-Ferrer, and Klaus Pantel, and Heidi Schwarzenbach
March 2011, The Lancet. Oncology,
Copied contents to your clipboard!